Risk of Influenza Infection In A Vaccinated Obese Population
接种疫苗的肥胖人群感染流感的风险
基本信息
- 批准号:8447408
- 负责人:
- 金额:$ 54.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-12-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAfrican AmericanAmericanAntibodiesAntibody FormationAntigensCD8B1 geneCenters for Disease Control and Prevention (U.S.)Clinical ResearchCytotoxic T-LymphocytesDataDisease OutbreaksDropsEffectivenessElderlyEnzyme-Linked Immunosorbent AssayEpidemicFailureGoalsGrantHealth StatusHospitalizationImmune System DiseasesImmune responseImmune systemIndividualInfectionInfluenzaInfluenza A Virus, H1N1 SubtypeInfluenza vaccinationMeasuresMemoryMorbidity - disease rateObesityOverweightPersonsPopulationPopulation StudyRecruitment ActivityReportingResearchResearch Project GrantsResourcesRiskRisk FactorsST14 geneSeasonsStudy SubjectSymptomsT cell responseT-LymphocyteTimeVaccinatedVaccinationVaccinesWeightaging populationbasedemographicsdesigndisorder preventionfluinfluenza virus vaccineinfluenzavirusinsightmortalitypandemic diseasepandemic influenzapathogenpreventprogramsresponseseasonal influenza
项目摘要
DESCRIPTION (provided by applicant): Infection with influenza virus is responsible for a great deal of morbidity and mortality worldwide. In non-pandemic years, 10-20% of the population in the US is infected with influenza virus. In any given year, more than 120,000 persons are hospitalized and 36,000 Americans die from influenza and influenza-related complications. In the case of an influenza pandemic, each of these measures of morbidity and mortality would greatly increase. With the recent report that pandemic H1N1 influenza causes increased morbidity and mortality in an obese population, it is extremely important to determine if obese individuals are at an increased risk for influenza vaccine failure. Our preliminary data demonstrates that obese individuals have a steeper drop influenza specific antibody over time following vaccination compared with healthy weight individuals. In addition, cytotoxic T lymphocytes (CD8+) from obese individuals have a poorer response to influenza antigen stimulation in comparison with healthy weight individuals. This application is designed to determine if the obese population will have a higher rate of influenza infection and more severe symptoms when compared with healthy weight vaccinated individuals The elderly population has a higher rate of vaccine failure compared to a younger population, and many of the immune dysfunctions seen in the elderly (reduced antibody responses, impaired T cell reactivity) have also been found in the obese. This suggests that, similar to an aging population, an obese population may not respond adequately to flu vaccination. Our study will answer the following questions relating to vaccine responsiveness in an obese population: Does influenza vaccination fail to protect obese individuals from influenza infection to the same degree as healthy weight individuals? How rapidly does the antibody titer drop over time in a vaccinated obese population? What is the mechanistic basis for the diminished CD8 T cell response to vaccination in an obese individual? If we determine that obesity is associated with an impaired immune response to influenza vaccination and decreased protection against influenza infection, this would suggest that we need to re-evaluate our vaccination program, not only for influenza, but perhaps for other pathogens as well, in an increasingly obese US population.
描述(由申请人提供):流感病毒的感染负责全球发病率和死亡率。在非大流行年中,美国有10-20%的人口感染了流感病毒。在任何给定的年份中,超过12万人住院,36,000名美国人死于流感和与流感有关的并发症。在流感大流行的情况下,这些发病率和死亡率的措施中的每一个都将大大增加。最近的报道称,大流行的H1N1流感会导致肥胖人群的发病率和死亡率增加,确定肥胖个体是否处于流感疫苗衰竭的风险增加非常重要。我们的初步数据表明,与健康的体重个体相比,肥胖个体随着时间的流逝,随着时间的推移,特异性抗体的下降幅度更高。此外,与健康体重个体相比,肥胖个体的细胞毒性T淋巴细胞(CD8+)对流感抗原刺激的反应较差。该应用旨在确定与健康的体重疫苗接种个体相比,与年轻人群相比,肥胖人群是否具有更高的流感感染率和更严重的症状,与年轻人的疫苗失败率更高,并且在老年人中看到的许多免疫功能障碍(抗体反应降低,T型T细胞反应性降低)也发现了肥胖症。这表明,与人口老龄化类似,肥胖人群可能对流感疫苗接种反应不足。我们的研究将回答肥胖人群中与疫苗反应性有关的以下问题:流感疫苗接种是否无法保护肥胖个体免受与健康体重个体相同程度的流感感染?在接种肥胖的肥胖人群中,抗体滴度随着时间的流逝而下降的速度如何?肥胖个体中CD8 T细胞对疫苗接种的反应减少的机理基础是什么?如果我们确定肥胖症与对流感疫苗接种的免疫反应受损和对流感感染的保护减少有关,这将表明我们需要重新评估我们的疫苗接种计划,不仅是流感,而且对于其他病原体也可能是越来越多的肥胖者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melinda A. Beck其他文献
Melinda A. Beck的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melinda A. Beck', 18)}}的其他基金
Nutritional Biocliemistry and Metabolomics Core
营养生物化学和代谢组学核心
- 批准号:
8132730 - 财政年份:2011
- 资助金额:
$ 54.49万 - 项目类别:
FASEB SRC on Nutritional Immunology: Its effects on health and disease.
FASEB SRC 关于营养免疫学:其对健康和疾病的影响。
- 批准号:
8128148 - 财政年份:2011
- 资助金额:
$ 54.49万 - 项目类别:
Risk of Influenza Infection In A Vaccinated Obese Population
接种疫苗的肥胖人群感染流感的风险
- 批准号:
8002059 - 财政年份:2008
- 资助金额:
$ 54.49万 - 项目类别:
Risk of Influenza Infection In A Vaccinated Obese Population
接种疫苗的肥胖人群感染流感的风险
- 批准号:
7740806 - 财政年份:2008
- 资助金额:
$ 54.49万 - 项目类别:
Risk of Influenza Infection In A Vaccinated Obese Population
接种疫苗的肥胖人群感染流感的风险
- 批准号:
7584481 - 财政年份:2008
- 资助金额:
$ 54.49万 - 项目类别:
Risk of Influenza Infection In A Vaccinated Obese Population
接种疫苗的肥胖人群感染流感的风险
- 批准号:
8232443 - 财政年份:2008
- 资助金额:
$ 54.49万 - 项目类别:
Risk of Influenza Infection In A Vaccinated Obese Population
接种疫苗的肥胖人群感染流感的风险
- 批准号:
8639445 - 财政年份:2008
- 资助金额:
$ 54.49万 - 项目类别:
相似海外基金
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 54.49万 - 项目类别:
DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
- 批准号:
10558119 - 财政年份:2023
- 资助金额:
$ 54.49万 - 项目类别:
Increasing initiation of evidence-based weight loss treatment
越来越多地开始开展循证减肥治疗
- 批准号:
10735201 - 财政年份:2023
- 资助金额:
$ 54.49万 - 项目类别:
StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)
旨在提高酒精戒断率的研究(奉献)
- 批准号:
10577022 - 财政年份:2023
- 资助金额:
$ 54.49万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 54.49万 - 项目类别: